Anzatax

 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Paclitaxel

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity.
OBJECTIVE Low water solubility, high systemic toxicity and insignificant cellular uptake have limited efficient clinical… (More)
Is this relevant?
2016
2016
Non-invasive endotracheal delivery of paclitaxel-loaded alginate microparticles.
Aerosolized chemotherapeutics leads to higher, localized and continuous concentrations of active agents in lung tissue with lower… (More)
Is this relevant?
2015
2015
A Rapid and Sensitive HPLC Method for Quantitation of Paclitaxel in Biological Samples using Liquid-Liquid Extraction and UV Detection: Application to Pharmacokinetics and Tissues Distribution Study…
A simple, rapid, and sensitive reversed-phase HPLC method was developed and validated for determination of paclitaxel (PTX) in… (More)
Is this relevant?
2015
2015
Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel.
In this study a novel receptor-targeted micelle delivery system based on tocopherol succinate-chitosan-polyethylene glycol-folic… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2014
2014
In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
A water-insoluble anti-tumor agent, paclitaxel (PTX) was successfully incorporated into novel-targeted polymeric micelles based… (More)
Is this relevant?
2008
2008
The clinical study of combined chemotherapy based on anzatax and cisplatin in the treatment of non-small cell lung cancer
 
Is this relevant?
2001
2001
Salvage therapy with single-agent paclitaxel by three-hour infusion in metastatic breast cancer: an experience in Taipei Veterans General Hospital.
BACKGROUND Paclitaxel is an active agent in the treatment of breast, ovarian, lung and head and neck cancers. In previous phase I… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1998
1998
Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer.
BACKGROUND Despite its moderate anti-tumour activity in head and neck cancers there have been no reports on the activity of… (More)
Is this relevant?
1997
1997
Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy.
OBJECTIVE To determine the efficacy and safety of paclitaxel given as a three-hour infusion in patients with metastatic breast… (More)
Is this relevant?